A detailed history of Mid American Wealth Advisory Group, Inc. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Mid American Wealth Advisory Group, Inc. holds 54 shares of PLRX stock, worth $82. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54
Holding current value
$82
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 30, 2025

BUY
$1.16 - $1.69 $62 - $91
54 New
54 $63,000

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $74M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Mid American Wealth Advisory Group, Inc. Portfolio

Follow Mid American Wealth Advisory Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mid American Wealth Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mid American Wealth Advisory Group, Inc. with notifications on news.